-
1
Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trial
Published 2025-01-01Subjects: Get full text
Article -
2
Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia
Published 2024-11-01Subjects: Get full text
Article